Here are five quick notes:
1. Ms. Schweiger previously served as vice president of clinical studies and regulatory affairs for Flowonix Medical in Budd Lake, N.J.
2. She’s also had experience developing and completing both European and U.S. clinical feasibility studies during her time at Flowonix.
3. Ms. Schweiger joins the ranks of Medovex as the company moves forward with earning the CE mark for its DenerveX System in the first half of 2017.
4. The DenerveX System includes the DenerveX device and the DenerveX Pro-40 Power Generator.
5. The system is not commercially available at the moment.
More articles on quality & infection control:
Gender equality correlates with rate of infectious diseases: 4 things to know
Patient-centered checklist may reap higher patient satisfaction, better surgical care for ASCs: 5 thoughts
HAIs testing market to surge to $2.8B by 2025: 3 points
